scholarly journals Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial

2019 ◽  
Vol 43 (1) ◽  
pp. 43-49
Author(s):  
Jonathan W. Cunningham ◽  
Jie‐Lena Sun ◽  
Finnian R. Mc Causland ◽  
Samantha Ly ◽  
Kevin J. Anstrom ◽  
...  
Keyword(s):  
Heart Failure ◽  
Length Of Stay ◽  
Acute Heart Failure ◽  
Urine Sodium ◽  
Heart Failure Patients ◽  
The Rose

scholarly journals Urine Sodium Content is Highly Variable in Hospitalized Acute Heart Failure Patients: Lasix Urine is Not Necessarily “Half-Normal Saline”

2017 ◽  
Vol 23 (8) ◽  
pp. S7
Author(s):  
Daniel Hodson ◽  
Keyanna Jackson ◽  
Zobia Chunara ◽  
Veena Rao ◽  
Devin Mahoney ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Normal Saline ◽  
Sodium Content ◽  
Urine Sodium ◽  
Heart Failure Patients

scholarly journals Factors that influence the length of hospitalization for acute heart failure patients in RSUP Dr. M Djamil

2020 ◽  
Vol 14 (1) ◽  
Author(s):  
M. Syaoqi ◽  
Andri Andri ◽  
Citra Kiki Krevani ◽  
Muhammad Syukri
Keyword(s):  
Heart Failure ◽  
Length Of Stay ◽  
Acute Heart Failure ◽  
Medical Records ◽  
Average Length ◽  
Descriptive Analysis ◽  
Heart Failure Patients ◽  
Average Length Of Stay ◽  
Baseline Characteristics ◽  
Length Of Hospitalization

More than 500,000 new patients were diagnosed with heart failure each year in all developing countries. Previous studies had shown that longer hospitalizations for patients with acute heart failure are associated with worse outcome. We analyzed factors that influence length of stay in our centre. We used a retrospective and descriptive analysis of acute heart failure patients at RSUP DR. M. Djamil from January to March 2018. We collected patient data from medical records including baseline characteristics, laboratory and echocardiographic results. We used statistical analysis to find the average length of stay (LOS) and possible causes of longer hospitalization. Among 30 patients had been collected, mean LOS was 6.23 days. Mean for age, BMI, and LVEF were 59.87 years, 23.55 kg/m2, and 36.93%, respectively. Patients those had LOS > 6 days may had relationship with initial degree edema pretibial (p=0.025) and systolic BP below 120 mmHg (p=0.018), but no significant with rales (p=0.543) and pulmonary infection (p=0.709). Length of stay associated with the degree of pretibial pitting edema and systolic blood pressure at admission.

Length of Stay and Readmission Rates in Pediatric Acute Heart Failure

2021 ◽  
Vol 40 (4) ◽  
pp. S122-S123
Author(s):  
D.S. Burstein ◽  
C. Connelly ◽  
C.S. Almond ◽  
R.A. Niebler ◽  
J.A. Godown ◽  
...  
Keyword(s):  
Heart Failure ◽  
Length Of Stay ◽  
Acute Heart Failure ◽  
Readmission Rates

scholarly journals Predictors of diuresis response to levosimendan administration in patients with acute heart failure

2021 ◽  
Vol 10 (Supplement_1) ◽  
Author(s):  
J Plonka ◽  
J Bugajski ◽  
M Plonka ◽  
A Tycinska ◽  
M Gierlotka
Keyword(s):  
Heart Failure ◽  
High Risk ◽  
Acute Heart Failure ◽  
Clinical Status ◽  
Older Age ◽  
Analysis Model ◽  
Heart Failure Patients ◽  
Positive Effects ◽  
Pulmonary Hemodynamic ◽  
Recent Acute Myocardial Infarction

Abstract Funding Acknowledgements Type of funding sources: None. Levosimendan, a calcium sensitizer and potassium channel-opener, is appreciated  for its effects on systemic and pulmonary hemodynamic and for the relief of symptoms in acute heart failure (AHF). Positive effects of levosimendan on renal function have been also described. The aim of the present analysis was to assess the predictors of the diuresis response to levosimendan administration in high risk acute heart failure patients. Methods. We analysed 34 consecutive patients admitted with high risk AHF to one centre and treated in intensive cardiac care unit. Levosimendan was administered on top of other treatment as a 24-hour infusion of 12.5 mg total dose except for 7 patients (1 patient - terminated earlier due to intolerance, 5 patients – 48h infusion, 1 patient - 72h infusion). Decision of levosimendan administration was based on clinical status and left to attending physician. Diuresis and diuretic dosage before (24 hours) and after levosimendan infusion (48 hours) were taken into account for the present study. Results. The AHF was primary of cardiac origin in all patients. In 6 (18%) it was due to recent acute myocardial infarction. In-hospital mortality was 24%. Median length of hospitalization was 26 days (range 6 to 107 days). Mean age of the patients was 66 ± 12 years, 25 (74%) were men. Mean INTERMACS score was 3.4 ± 1.4 with wet-cold clinical profile present in 13 (38%) of patients. Mean left ventricle ejection fraction (LVEF) was 27 ± 13%, mean NTproBNP was 17176 ± 12464 pg/ml, and mean eGFR 48 ± 22 ml/min/1.73m2. At the time of levosimendan administration patients had background treatment with catecholamines (mean number per patient 1.4 ± 1.1, range 0-3) and with diuretics (mean dosage of furosemide 167 ± 102 mg/24h, range 20-500). 48-hours diuresis after levosimendan administration varies from 950 to 11300 ml (mean 4307 ± 2418 ml). It was significantly lower in patients with cold-wet profile (2646 ± 1335 vs. 5335 ± 2381 ml in other clinical profiles, p = 0.0002). Additionally, 48-hour diuresis was negatively correlated with age (r=-0.46, p = 0.0062) and the number of background catecholamines (r=-0.47, p = 0.0047), and not significantly with the furosemide dosage (r=-0.28, p = 0.10) – figure. No association with diuresis was found for LVEF, NTproBNP, and eGFR. In multiple regression analysis (model R2 = 0.63, p = 0.0085) both older age (p = 0.026) and cold-wet profile (p = 0.0074) were significant predictors of poor diuresis after levosimendan administration. Conclusion. Older age and cold-wet profile were significant predictors of poor diuresis response to levosimendan administration in high risk acute heart failure patients. Although concomitant catecholamines and high diuretic dosage use cloud also be markers of non-responders to levosimendan in terms of diuresis. Abstract Figure

scholarly journals Early Ambulation Among Hospitalized Heart Failure Patients Is Associated With Reduced Length of Stay and 30-Day Readmissions

2018 ◽  
Vol 11 (4) ◽  
Author(s):  
Lisa M. Fleming ◽  
Xin Zhao ◽  
Adam D. DeVore ◽  
Paul A. Heidenreich ◽  
Clyde W. Yancy ◽  
...  
Keyword(s):  
Heart Failure ◽  
Length Of Stay ◽  
Early Ambulation ◽  
Heart Failure Patients

scholarly journals Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial

2017 ◽  
Vol 106 (6) ◽  
pp. 444-456 ◽  
Author(s):  
Gerasimos Filippatos ◽  
Dimitrios Farmakis ◽  
Marco Metra ◽  
Gad Cotter ◽  
Beth A. Davison ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Acute Heart Failure ◽  
Secondary Analysis ◽  
Heart Failure Patients
Sign in / Sign up

Export Citation Format

Share Document